News and Trends 2 Nov 2022Authorization given to BeiGene’s chemo-free treatment option for lymphoma Marketing authorization has been granted to a drug to treat relapsed/refractory (R/R) marginal zone lymphoma (MZL) without chemotherapy, it was… November 2, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email